Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018339

10% owner acquired 7,911,455 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Third Rock Ventures IV, L.P. 10% owner 2018-06-25 Conversion +7,911,455 8,008,204 D
Derivatives
Third Rock Ventures IV, L.P. 10% owner 2018-06-25 Conversion · Series A Preferred Stock −20,102,478 0 D
Third Rock Ventures IV, L.P. 10% owner 2018-06-25 Conversion · Series B Preferred Stock −340,566 0 D
Loading xslF345X03/doc4.xml…